Ruxolitinib is an effective steroid sparing agent in children with steroid refractory/dependent bronchiolitis obliterans syndrome after allogenic hematopoietic cell transplantation - Schoettler, M; Duncan, C; Lehmann, L; Furutani, E; Subramaniam, M; Margossian, S (Bone Marrow Transplant, 2019)